Synthesis of thiocarbohydrazide and carbohydrazide derivatives as possible biologically active agents. 2014

Kiran Gangarapu, and Sarangapani Manda, and Anvesh Jallapally, and Sreekanth Thota, and Subhas S Karki, and Jan Balzarini, and Erik De Clercq, and Harukuni Tokuda
Department of Pharmaceutical Chemistry, Kakatiya Institute of Pharmaceutical Sciences, Pembarthy (V), Hasanparthy (M), Warangal, 506 371 AP India.

A series of new β-isatin aldehyde-N,N'-thiocarbohydrazone, bis-β-isatin thiocarbohydrazones, bis-β-isatin carbohydrazones was synthesized by condensation of 5-substituted isatin with thiocarbohydrazide or carbohydrazide. The chemical structures of the newly synthesized compounds were confirmed by FT-IR, 1H NMR, and mass spectral analysis. The synthesized compounds were evaluated for in vitro antiviral activity against various strains of DNA and RNA viruses, but exhibited moderate antiviral activity compared with the reference compounds. Among all the compounds 6c exhibited the highest chemoprevention activity in a two-stage mouse-skin carcinogenesis test.

UI MeSH Term Description Entries

Related Publications

Kiran Gangarapu, and Sarangapani Manda, and Anvesh Jallapally, and Sreekanth Thota, and Subhas S Karki, and Jan Balzarini, and Erik De Clercq, and Harukuni Tokuda
June 1985, Talanta,
Kiran Gangarapu, and Sarangapani Manda, and Anvesh Jallapally, and Sreekanth Thota, and Subhas S Karki, and Jan Balzarini, and Erik De Clercq, and Harukuni Tokuda
July 2016, Acta poloniae pharmaceutica,
Kiran Gangarapu, and Sarangapani Manda, and Anvesh Jallapally, and Sreekanth Thota, and Subhas S Karki, and Jan Balzarini, and Erik De Clercq, and Harukuni Tokuda
May 1986, Arzneimittel-Forschung,
Kiran Gangarapu, and Sarangapani Manda, and Anvesh Jallapally, and Sreekanth Thota, and Subhas S Karki, and Jan Balzarini, and Erik De Clercq, and Harukuni Tokuda
February 1970, Chemical reviews,
Kiran Gangarapu, and Sarangapani Manda, and Anvesh Jallapally, and Sreekanth Thota, and Subhas S Karki, and Jan Balzarini, and Erik De Clercq, and Harukuni Tokuda
July 1977, Die Pharmazie,
Kiran Gangarapu, and Sarangapani Manda, and Anvesh Jallapally, and Sreekanth Thota, and Subhas S Karki, and Jan Balzarini, and Erik De Clercq, and Harukuni Tokuda
November 2011, European journal of medicinal chemistry,
Kiran Gangarapu, and Sarangapani Manda, and Anvesh Jallapally, and Sreekanth Thota, and Subhas S Karki, and Jan Balzarini, and Erik De Clercq, and Harukuni Tokuda
January 2019, Current medicinal chemistry,
Kiran Gangarapu, and Sarangapani Manda, and Anvesh Jallapally, and Sreekanth Thota, and Subhas S Karki, and Jan Balzarini, and Erik De Clercq, and Harukuni Tokuda
March 2011, Bioorganic & medicinal chemistry,
Kiran Gangarapu, and Sarangapani Manda, and Anvesh Jallapally, and Sreekanth Thota, and Subhas S Karki, and Jan Balzarini, and Erik De Clercq, and Harukuni Tokuda
October 1997, Die Pharmazie,
Kiran Gangarapu, and Sarangapani Manda, and Anvesh Jallapally, and Sreekanth Thota, and Subhas S Karki, and Jan Balzarini, and Erik De Clercq, and Harukuni Tokuda
May 1988, Talanta,
Copied contents to your clipboard!